A citation-based method for searching scientific literature

Christine Van Cott. Surg Clin North Am 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
Doua Bakry, Melyssa Aronson, Carol Durno, Hala Rimawi, Roula Farah, Qasim Kholaif Alharbi, Musa Alharbi, Ashraf Shamvil, Shay Ben-Shachar, Matthew Mistry,[...]. Eur J Cancer 2014
112
50

Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations.
Lise B Ahlborn, Ane Y Steffensen, Lars Jønson, Malene Djursby, Finn C Nielsen, Anne-Marie Gerdes, Thomas V O Hansen. Fam Cancer 2015
8
50

Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer.
Suzana S Couto, Mei Cao, Paulo C Duarte, Whitney Banach-Petrosky, Shunyou Wang, Peter Romanienko, Hong Wu, Robert D Cardiff, Cory Abate-Shen, Gerald R Cunha. Differentiation 2009
26
50

A case of endometrial cancer in the context of a BRCA2 mutation and double heterozygosity for Lynch syndrome.
Ping Gong, Sarah Charles, Norman Rosenblum, Zoe Wang, Agnieszka K Witkiewicz. Gynecol Oncol Case Rep 2012
5
50

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
543
50

BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Christian Monnerat, Agnès Chompret, Caroline Kannengiesser, Marie-Françoise Avril, Nicolas Janin, Alain Spatz, Jean-Marc Guinebretière, Catalin Marian, Michel Barrois, Françoise Boitier,[...]. Fam Cancer 2007
29
50

What 20 years of research has taught us about the TP53 p.R337H mutation.
Emilia Modolo Pinto, Gerard P Zambetti. Cancer 2020
5
50

Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report.
Raquel Andrés, Sebastian Menao, María Arruebo, Elisa Quílez, Maria José Cardiel. Breast Cancer Res Treat 2019
4
50

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.
Garrett M Frampton, Alex Fichtenholtz, Geoff A Otto, Kai Wang, Sean R Downing, Jie He, Michael Schnall-Levin, Jared White, Eric M Sanford, Peter An,[...]. Nat Biotechnol 2013
50

Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer.
Takeshi Murata, Chikashi Watase, Sho Shiino, Kenjiro Jimbo, Eriko Iwamoto, Masayuki Yoshida, Shin Takayama, Akihiko Suto. Clin Breast Cancer 2021
2
50

Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer.
K Bell, N Hodgson, M Levine, B Sadikovic, K Zbuk. Breast Cancer Res Treat 2014
1
100

Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
Siranoush Manoukian, Bernard Peissel, Valeria Pensotti, Monica Barile, Laura Cortesi, Silvia Stacchiotti, Monica Terenziani, Floriana Barbera, Graziella Pasquini, Simona Frigerio,[...]. Eur J Cancer 2007
36
50

Multilocus Inherited Neoplasia Alleles Syndrome: A Case Series and Review.
James Whitworth, Anne-Bine Skytte, Lone Sunde, Derek H Lim, Mark J Arends, Lisa Happerfield, Ian M Frayling, Rick van Minkelen, Emma R Woodward, Marc D Tischkowitz,[...]. JAMA Oncol 2016
25
50

Li-Fraumeni Syndrome.
Hernán Correa. J Pediatr Genet 2016
24
50


A Rare TP53 Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple Cancers.
Jacquelyn Powers, Emilia M Pinto, Thibaut Barnoud, Jessica C Leung, Tetyana Martynyuk, Andrew V Kossenkov, Aaron H Philips, Heena Desai, Ryan Hausler, Gregory Kelly,[...]. Cancer Res 2020
4
50

Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.
Anna P Sokolenko, Maxim E Rozanov, Natalia V Mitiushkina, Natalia Yu Sherina, Aglaya G Iyevleva, Elena V Chekmariova, Konstantin G Buslov, Evgeny S Shilov, Alexandr V Togo, Elena M Bit-Sava,[...]. Fam Cancer 2007
51
50

clusterProfiler: an R package for comparing biological themes among gene clusters.
Guangchuang Yu, Li-Gen Wang, Yanyan Han, Qing-Yu He. OMICS 2012
50

Statistical predictions with glmnet.
Solveig Engebretsen, Jon Bohlin. Clin Epigenetics 2019
56
50

Visualizing and interpreting cancer genomics data via the Xena platform.
Mary J Goldman, Brian Craft, Mim Hastie, Kristupas Repečka, Fran McDade, Akhil Kamath, Ayan Banerjee, Yunhai Luo, Dave Rogers, Angela N Brooks,[...]. Nat Biotechnol 2020
238
50

LINC00893 inhibits papillary thyroid cancer by suppressing AKT pathway via stabilizing PTEN.
Shujing Li, Yanyan Zhang, Jian Dong, Ruihuan Li, Bo Yu, Wenjun Zhao, Jing Liu. Cancer Biomark 2021
2
50


Long non-coding RNA SNHG9 inhibits ovarian cancer progression by sponging microRNA-214-5p.
Gao-Yang Chen, Zhi-Sheng Zhang, Yu Chen, Yan Li. Oncol Lett 2021
2
50

Low-grade serous ovarian cancer: A review.
Anis Kaldawy, Yakir Segev, Ofer Lavie, Ron Auslender, Victoria Sopik, Steven A Narod. Gynecol Oncol 2016
70
50

LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
Eleonora A Braga, Marina V Fridman, Alexey A Moscovtsev, Elena A Filippova, Alexey A Dmitriev, Nikolay E Kushlinskii. Int J Mol Sci 2020
11
50

NCBI GEO: mining millions of expression profiles--database and tools.
Tanya Barrett, Tugba O Suzek, Dennis B Troup, Stephen E Wilhite, Wing-Chi Ngau, Pierre Ledoux, Dmitry Rudnev, Alex E Lash, Wataru Fujibuchi, Ron Edgar. Nucleic Acids Res 2005
678
50

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
Martin C Tammemägi, Kevin Ten Haaf, Iakovos Toumazis, Chung Yin Kong, Summer S Han, Jihyoun Jeon, John Commins, Thomas Riley, Rafael Meza. JAMA Netw Open 2019
26
50


Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.
Zahra Sadat Razavi, Vida Tajiknia, Shahab Majidi, Maryam Ghandali, Hamid Reza Mirzaei, Neda Rahimian, Michael R Hamblin, Hamed Mirzaei. Crit Rev Oncol Hematol 2021
25
50


A novel three-long noncoding RNA risk score system for the prognostic prediction of triple-negative breast cancer.
Chao Yuan, Hongjun Yuan, Li Chen, Miaomiao Sheng, Wenru Tang. Biomark Med 2021
2
50

miRTarBase: a database curates experimentally validated microRNA-target interactions.
Sheng-Da Hsu, Feng-Mao Lin, Wei-Yun Wu, Chao Liang, Wei-Chih Huang, Wen-Ling Chan, Wen-Ting Tsai, Goun-Zhou Chen, Chia-Jung Lee, Chih-Min Chiu,[...]. Nucleic Acids Res 2011
746
50



LncRNAs in ovarian cancer.
Jin-Yan Wang, Ai-Qing Lu, Li-Juan Chen. Clin Chim Acta 2019
26
50

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
Jessica A Cintolo-Gonzalez, Danielle Braun, Amanda L Blackford, Emanuele Mazzola, Ahmet Acar, Jennifer K Plichta, Molly Griffin, Kevin S Hughes. Breast Cancer Res Treat 2017
66
50

A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
Priyanka Kulkarni, Pritha Dasgupta, Yutaka Hashimoto, Marisa Shiina, Varahram Shahryari, Z Laura Tabatabai, Soichiro Yamamura, Yuichiro Tanaka, Sharanjot Saini, Rajvir Dahiya,[...]. Cancer Res 2021
3
50


Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
Wei Guo, Zhiming Dong, Yabin Shi, Shengnan Liu, Jia Liang, Yanli Guo, Xin Guo, Supeng Shen, Baoen Shan. Dig Liver Dis 2016
19
50


Knockdown of lncRNA MIR503HG suppresses proliferation and promotes apoptosis of non-small cell lung cancer cells by regulating miR-489-3p and miR-625-5p.
Runa Dao, Muli Wudu, Linping Hui, Jun Jiang, Yitong Xu, Hongjiu Ren, Xueshan Qiu. Pathol Res Pract 2020
7
50

Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
Pihua Han, Haiming Yang, Xiang Li, Jie Wu, Peili Wang, Dapeng Liu, Guodong Xiao, Xin Sun, Hong Ren. Oncol Res 2021
1
100

Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
Li-Hua Luo, Min Jin, Lan-Qing Wang, Guo-Jie Xu, Zhen-Yu Lin, Dan-Dan Yu, Sheng-Li Yang, Rui-Zhi Ran, Gang Wu, Tao Zhang. J Cell Physiol 2020
12
50


Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma.
Jianguo Li, Jin Zhou, Shuangshuang Kai, Can Wang, Daijun Wang, Jiying Jiang. Biomed Res Int 2020
1
100

Gene co-expression network reveals shared modules predictive of stage and grade in serous ovarian cancers.
Qian Sun, Haiyue Zhao, Cong Zhang, Ting Hu, Jianli Wu, Xingguang Lin, Danfeng Luo, Changyu Wang, Li Meng, Ling Xi,[...]. Oncotarget 2017
24
50

Long non-coding RNA MIR503HG serves as a tumor suppressor in non-small cell lung cancer mediated by wnt1.
H Lin, P Li, N Zhang, L Cao, Y-F Gao, F Ping. Eur Rev Med Pharmacol Sci 2019
6
50

LncRNA MIR503HG inhibits cell migration and invasion via miR-103/OLFM4 axis in triple negative breast cancer.
Jia Fu, Guanjun Dong, Hui Shi, Junfeng Zhang, Zhaochen Ning, Xingna Bao, Chenjie Liu, Jing Hu, Minghui Liu, Bin Xiong. J Cell Mol Med 2019
28
50


The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
Naibin Yang, Shanshan Li, Guoxiang Li, Shengguo Zhang, Xinyue Tang, Shunlan Ni, Xiaomin Jian, Cunlai Xu, Jiayin Zhu, Mingqin Lu. Oncotarget 2017
47
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.